Silk Road Medical to Present at the Morgan Stanley 20th Annual Global Healthcare Conference

Rhea-AI Summary

Silk Road Medical, a company dedicated to reducing stroke risks, will participate in the Morgan Stanley 20th Annual Global Healthcare Conference in New York. The presentation is scheduled for September 13, 2022, at 12:55 p.m. Eastern Time. Interested parties can access the live and archived webcast on the company's website. Silk Road Medical specializes in a pioneering procedure known as TransCarotid Artery Revascularization (TCAR), which combines surgical and endovascular techniques to treat carotid artery blockages effectively.

SUNNYVALE, Calif., Aug. 30, 2022 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the company will be participating in a fireside chat at the upcoming Morgan Stanley 20th Annual Global Healthcare Conference held in New York, New York.

Silk Road Medical’s management is scheduled to present on Tuesday, September 13, 2022 at 12:55 p.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company’s website at: https://investors.silkroadmed.com/.

About Silk Road Medical
Silk Road Medical, Inc. (NASDAQ: SILK), is a medical device company located in Sunnyvale, California, and Plymouth, Minnesota, that is focused on reducing the risk of stroke and its devastating impact. The company has pioneered a new approach for the treatment of carotid artery disease called TransCarotid Artery Revascularization (TCAR). TCAR is a clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a stroke. For more information on how Silk Road Medical is delivering brighter patient outcomes through brighter clinical thinking, visit www.silkroadmed.com and connect on Twitter, LinkedIn and Facebook.

Investor Contact:
Lynn Lewis or Marissa Bych
Gilmartin Group
investors@silkroadmed.com

Media:
Michael Fanucchi
Silk Road Medical
mfanucchi@silkroadmed.com

FAQ

When will Silk Road Medical participate in the Morgan Stanley conference?

Silk Road Medical will participate in the Morgan Stanley 20th Annual Global Healthcare Conference on September 13, 2022, at 12:55 p.m. Eastern Time.

How can I watch Silk Road Medical's presentation at the conference?

You can watch Silk Road Medical's presentation live or access the archived webcast on the company's 'Investors' section of their website.

What is the focus of Silk Road Medical?

Silk Road Medical focuses on reducing the risk of stroke through innovative medical devices and procedures, particularly the TransCarotid Artery Revascularization (TCAR).

What is TCAR and its significance?

TCAR stands for TransCarotid Artery Revascularization, a clinically proven procedure that combines surgical principles with minimally invasive techniques to treat carotid artery blockages, significantly reducing stroke risks.